STOP Nitazenes Act
Bill Summary
Bans the production and distribution of nitazenes, a type of synthetic opioid. Requires the federal government to regulate nitazenes as a controlled substance.
Sponsored By
Bill Journey
- Mar 18, 2026
- Mar 18, 2026You Are Here
The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.
- TBD
The full chamber debates the bill, may amend it, and votes on whether to pass it.
- TBD
If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.
- TBD
If passed by both chambers, the bill goes to the President to sign into law or veto.
Why It Matters
This bill affects individuals who manufacture, distribute, or use nitazenes, as well as law enforcement agencies and public health organizations that deal with opioid-related issues. It would lead to increased penalties for those involved in the production and distribution of nitazenes, and potentially reduce the availability of these substances.
Impact Areas
Support & Opposition
- Democratic1
- Republican7
Documents
1
Full text opens on congress.gov, the official source.
Cosponsors (7)
Bill Details
- Safety
Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.







